All In MedTech

FDA Clearance Tracker · P170027

TherOx Downstream System

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Apr 2, 2019 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Apr 2, 2019

Approved

Time to decision

564 days

Received Sep 15, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P170027
Device name
TherOx Downstream System
Applicant location
San Jose, CA
Received
Sep 15, 2017
Decided
Apr 2, 2019
Decision
Approved
Supplements
20 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code MWG

FDA's approval statement

As written in FDA's record.

Approval for the TherOx Downstream System. This device is indicated for the preparation and delivery of SuperSaturated Oxygen Therapy (SSO2 Therapy) to targeted ischemic regions perfused by the patients left anterior descending coronary artery immediately following revascularization by means of percutaneous coronary intervention (PCI) with stenting that has been completed within 6 hours after the onset of anterior acute myocardial infarction (AMI) symptoms caused by a left anterior descending artery infarct lesion.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code MWG (System, oxygen, aqueous).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Zoll Circulation, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.